(68)Ga-PSMA PET/CT for Response Evaluation of (223)Ra Treatment in Metastatic Prostate Cancer. de Jong AC, Segbers M, Ling SW, Graven LH, et al. J Nucl Med 2023 Aug 3:jnumed.123.265489. doi: 10.2967/jnumed.123.265489.

Read + Share

Amedeo Smart

Independent Medical Education

de Jong AC, Segbers M, Ling SW, Graven LH, et al. (68)Ga-PSMA PET/CT for Response Evaluation of (223)Ra Treatment in Metastatic Prostate Cancer. J Nucl Med 2023 Aug 3:jnumed.123.265489. doi: 10.2967/jnumed.123.265489.
PMID: 37536738